Skip to content
ChickenStockChickenStock
Research195940
HK inno.N logo

HK inno.N (195940) stock

KOSDAQ · Pharmaceuticals

KRW 36,150+0.56%(+200)

As of the Nov 16 regular-session close (Korea)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

11.93x

P/B

0.76x

P/S

0.95x

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
Q2 2026Separate · Filed Aug 14, 2026KRW 267.2 billionKRW 30 billionKRW 13.7 billion+1.6%
Q1 2026Separate · Filed May 14, 2026KRW 258.7 billionKRW 33.2 billionKRW 25.9 billion+4.6%
Q4 2025Separate · Filed Mar 18, 2026KRW 291.9 billionKRW 40.1 billionKRW 27.7 billion—
Q3 2025Separate · Filed Nov 14, 2025KRW 260.8 billionKRW 25.9 billionKRW 18.6 billion+13.7%
Q2 2025Separate · Filed Aug 14, 2025KRW 263.1 billionKRW 19.5 billionKRW 12 billion+20.0%
Q1 2025Separate · Filed May 15, 2025KRW 247.4 billionKRW 25.4 billionKRW 17.4 billion+16.3%
Fiscal years
PeriodRevenueOperating profitNet incomeRevenue YoY
FY2025Separate · Filed Mar 18, 2026KRW 1.1 trillionKRW 110.9 billionKRW 75.7 billion—
FY2024Separate · Filed Mar 18, 2025KRW 897.1 billionKRW 88.2 billionKRW 61.6 billion—
  • Q2 2026 is computed as H1 2026 minus Q1 2026.
  • Q4 2025 is computed as FY2025 minus 9M 2025.
  • Q3 2025 is computed as 9M 2025 minus H1 2025.
  • Q2 2025 is computed as H1 2025 minus Q1 2025.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
3.51%
Of trading value on Nov 13, 2026
Short-sale value
KRW 170 million
Previous 20-day average 7.16%
Net short position
30,254 shares
As of Nov 11, 2026 · reported with a two-trading-day lag
Lending balance
1,779,093 shares
As of Nov 13, 2026 · 6.28% of listed shares
Recent short-sale days
DateShareValue
Nov 13, 20263.51%KRW 170 million
Nov 12, 20264.65%KRW 210 million
Nov 11, 20268.23%KRW 410 million
Nov 10, 20265.47%KRW 130 million
Nov 9, 20267.07%KRW 270 million
Nov 6, 20263.92%KRW 230 million
Nov 5, 20262.97%KRW 350 million
Nov 4, 20267.37%KRW 400 million
Nov 3, 202613.07%KRW 340 million
Nov 2, 20263.62%KRW 90 million

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

HK inno.N (195940) stock information

KOSDAQ

HK inno.N (195940) is listed on KOSDAQ. Its market capitalization is about KRW 1 trillion. On trailing-twelve-month earnings the P/E ratio is 11.93, and the P/B ratio is 0.76. Return on equity is 6.4%. These figures are computed in-house from official filings and are reference information only.

HK inno.N — frequently asked questions

What is the P/E ratio of HK inno.N (195940)?
On a trailing-twelve-month basis, 195940 trades at a P/E ratio of 11.93. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of HK inno.N?
195940 has a market capitalization of about KRW 1 trillion. The figure moves with the share price and is refreshed each trading day.
Does HK inno.N pay a dividend?
195940 has a dividend yield of about 1.13%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.